Marktanteil, Trends und Prognose zur antiviralen Arzneimittelresistenz bis 2031
Antiviral Drug Resistance Market: Strategic Insights
Antiviral Drug Resistance Market
CAGR (2023 - 2031)7.9%- Market Size 2023
US$ 3.44 Billion - Market Size 2031
US$ 6.35 Billion
Market
- Risisng Incidences of Hepatatic Diseases to Favor Market
- Increasing Prevalence of HIV/AIDs
- Increasing Healthcare Expenditures in Emerging Markets
Key
- AccuBioTech Co., Ltd.;
- ACON Laboratories, Inc.;
- Siemens AG;
- BioMérieux SA;
- Bio-Rad Laboratories, Inc.;
- Danaher;
- Abbott;
- BD ;
- F Hoffmann-La Roche Ltd.;
- Trinity Biotech
Regional
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market
- Kits & Reagents
- Instruments
- Human Immunodeficiency Virus
- Immunodiagnostics
- Polymerase Chain Reaction
- Hospitals & Clinics
- Pathology or Diagnostic Laboratories
- Research Institutes